These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 12853747

  • 1. Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals.
    Cooley L, Ayres A, Bartholomeusz A, Lewin S, Crowe S, Mijch A, Locarnini S, Sasadeusz J.
    AIDS; 2003 Jul 25; 17(11):1649-57. PubMed ID: 12853747
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
    Matthews GV, Bartholomeusz A, Locarnini S, Ayres A, Sasaduesz J, Seaberg E, Cooper DA, Lewin S, Dore GJ, Thio CL.
    AIDS; 2006 Apr 04; 20(6):863-70. PubMed ID: 16549970
    [Abstract] [Full Text] [Related]

  • 3. High incidence of lamivudine-resistance-associated vaccine-escape HBV mutants among HIV-coinfected patients on prolonged antiretroviral therapy.
    Pal A, Sarkar N, Saha D, Guha SK, Saha B, Chakrabarti S, Chakravarty R.
    Antivir Ther; 2015 Apr 04; 20(5):545-54. PubMed ID: 25654813
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiency virus/hepatitis B virus co-infected patients in Brazil.
    Silva AC, Spina AM, Lemos MF, Oba IT, Guastini Cde F, Gomes-Gouvêa MS, Pinho JR, Mendes-Correa MC.
    Mem Inst Oswaldo Cruz; 2010 Sep 04; 105(6):770-8. PubMed ID: 20944991
    [Abstract] [Full Text] [Related]

  • 5. High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B.
    Mendes-Correa MC, Pinho JR, Locarnini S, Yuen L, Sitnik R, Santana RA, Gomes-Gouvêa MS, Leite OM, Martins LG, Silva MH, Gianini RJ, Uip DE.
    J Med Virol; 2010 Sep 04; 82(9):1481-8. PubMed ID: 20648600
    [Abstract] [Full Text] [Related]

  • 6. Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
    Audsley J, Arrifin N, Yuen LK, Ayres A, Crowe SM, Bartholomeusz A, Locarnini SA, Mijch A, Lewin SR, Sasadeusz J.
    HIV Med; 2009 Apr 04; 10(4):229-35. PubMed ID: 19178592
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.
    Wongprasit P, Manosuthi W, Kiertiburanakul S, Sungkanuparph S.
    AIDS Patient Care STDS; 2010 Apr 04; 24(4):205-9. PubMed ID: 20377434
    [Abstract] [Full Text] [Related]

  • 8. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F, Vincenti D, Vairo F, Solmone M, Mariano A, Piselli P, Puro V, Capobianchi MR, Antonucci G.
    J Med Virol; 2009 Jul 04; 81(7):1151-6. PubMed ID: 19475624
    [Abstract] [Full Text] [Related]

  • 9. Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
    Belyhun Y, Liebert UG, Maier M.
    PLoS One; 2018 Jul 04; 13(2):e0191970. PubMed ID: 29408943
    [Abstract] [Full Text] [Related]

  • 10. Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study. CAESAR co-ordinating committee.
    Pillay D, Cane PA, Ratcliffe D, Atkins M, Cooper D.
    AIDS; 2000 Jun 16; 14(9):1111-6. PubMed ID: 10894274
    [Abstract] [Full Text] [Related]

  • 11. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.
    Sucupira MV, Mello FC, Santos EA, Niel C, Rolla VC, Arabe J, Gomes SA.
    Mem Inst Oswaldo Cruz; 2006 Sep 16; 101(6):655-60. PubMed ID: 17072479
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine.
    Santos EA, Sucupira MV, Arabe J, Gomes SA.
    BMC Infect Dis; 2004 Aug 31; 4():29. PubMed ID: 15339340
    [Abstract] [Full Text] [Related]

  • 13. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG, Lukhwareni A, Song E, Leeuw YG, Burnett RJ, Mphahlele MJ.
    J Med Virol; 2007 Nov 31; 79(11):1650-4. PubMed ID: 17854040
    [Abstract] [Full Text] [Related]

  • 14. The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia.
    Deressa T, Damtie D, Fonseca K, Gao S, Abate E, Alemu S, Aleka Y, Swain MG, van Marle G, Coffin CS.
    PLoS One; 2017 Nov 31; 12(12):e0190149. PubMed ID: 29281718
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients.
    Ramos B, Núñez M, Martín-Carbonero L, Sheldon J, Rios P, Labarga P, Romero M, Barreiro P, García-Samaniego J, Soriano V.
    J Acquir Immune Defic Syndr; 2007 Apr 15; 44(5):557-61. PubMed ID: 17224847
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O, Benhamou Y, Cahour A, Katlama C, Poynard T, Thibault V.
    Antivir Ther; 2004 Jun 15; 9(3):353-63. PubMed ID: 15259898
    [Abstract] [Full Text] [Related]

  • 17. Predominance of Hepatitis B Virus Genotype A Among Treated HIV Infected Patients Experiencing High Hepatitis B Virus Drug Resistance in Nairobi, Kenya.
    Mabeya SN, Ngugi C, Lihana RW, Khamadi SA, Nyamache AK.
    AIDS Res Hum Retroviruses; 2017 Sep 15; 33(9):966-969. PubMed ID: 28316253
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and resistance pattern of genotype G and H in chronic hepatitis B and HIV co-infected patients in Mexico.
    Mata Marín JA, Arroyo Anduiza CI, Calderón GM, Cazares Rodríguez S, Fuentes Allen JL, Arias Flores R, Gaytán Martínez J.
    Ann Hepatol; 2012 Sep 15; 11(1):47-51. PubMed ID: 22166560
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia.
    Tamandjou Tchuem CR, Brandt L, Nel ER, Cotton MF, Matthews P, Kaindjee-Tjituka F, Preiser W, Andersson MI.
    PLoS One; 2020 Sep 15; 15(9):e0238839. PubMed ID: 32915862
    [Abstract] [Full Text] [Related]

  • 20. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Hamers RL, Zaaijer HL, Wallis CL, Siwale M, Ive P, Botes ME, Sigaloff KC, Hoepelman AI, Stevens WS, Rinke de Wit TF, PharmAccess African Studies to Evaluate Resistance (PASER).
    J Acquir Immune Defic Syndr; 2013 Oct 01; 64(2):174-82. PubMed ID: 23892239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.